COVID-19

The anti-inflammatory drug hydroxychloroquine should not be used to prevent infection in people who do not have the novel coronavirus (COVID-19),

The U.S. Food and Drug Administration (FDA) issued late last week an emergency use authorization for the third novel coronavirus (COVID-19)

People grieving a novel coronavirus (COVID-19) related death would benefit from timely support and care to reduce the high risk of experiencing

A new approach to pooled novel coronavirus (COVID-19) testing can be a highly effective tool for curbing the SARS-CoV-2 pandemic, even if infections

In patients with severe cases of the novel coronavirus (COVID-19), the innate immune system overreacts, which may underlie the formation of blood

Among vaccine clinical trials in the United States, people who are Black, Native American, and Latino and age 65 years and older were the most

Levels of specific antibodies developed in the immune response may influence novel coronavirus (COVID-19) outcomes in both children and adults,

High-dose zinc and ascorbic acid supplementation has little effect on symptom length or hospitalization rates among novel coronavirus (COVID-19)